» Articles » PMID: 39435114

Bioactivities and Industrial Standardization Status of : A Comprehensive Review

Overview
Journal Heliyon
Specialty Social Sciences
Date 2024 Oct 22
PMID 39435114
Authors
Affiliations
Soon will be listed here.
Abstract

(GL) is a potent source of bioactive compounds with diverse nutritional and pharmacological benefits. Its popularity as a dietary supplement, herbal remedy, and wellness product is steadily on the rise. Furthermore, the standardized advancement of the GL industry has facilitated reliable sourcing of raw materials and quality control measures, enhancing its utilization and endorsement in the realms of nutritional science and pharmaceutical research. This article provides a comprehensive overview of the recent advancements in research pertaining to the bioactive components of GL, particularly polysaccharides (GLP) and triterpenes (GLTs) as well as highlights the latest findings regarding their beneficial effects on human diseases, including anticancer, antidiabetes, liver protection and other aspects (such as regulating gut microbiota, antioxidant, antimicrobial, antiinflammatory and immune regulation). Furthermore, we summarized the potential applications of GL in the food and pharmaceutical sectors, while also examining the current status of standardization throughout the entire industrial chain of GL, both domestically and internationally. These information offer an insight and guidance for the prospects of industrial development and the innovative advancement of GL within the global health industry.

References
1.
Wang Y, Yu F, Zheng X, Li J, Zhang Z, Zhang Q . Balancing adipocyte production and lipid metabolism to treat obesity-induced diabetes with a novel proteoglycan from Ganoderma lucidum. Lipids Health Dis. 2023; 22(1):120. PMC: 10408226. DOI: 10.1186/s12944-023-01880-6. View

2.
Zeng P, Guo Z, Zeng X, Hao C, Zhang Y, Zhang M . Chemical, biochemical, preclinical and clinical studies of Ganoderma lucidum polysaccharide as an approved drug for treating myopathy and other diseases in China. J Cell Mol Med. 2018; 22(7):3278-3297. PMC: 6010762. DOI: 10.1111/jcmm.13613. View

3.
Khursheed R, Singh S, Kumar B, Wadhwa S, Gulati M, A A . Self-nanoemulsifying composition containing curcumin, quercetin, Ganoderma lucidum extract powder and probiotics for effective treatment of type 2 diabetes mellitus in streptozotocin induced rats. Int J Pharm. 2021; 612:121306. DOI: 10.1016/j.ijpharm.2021.121306. View

4.
Ekiz E, Oz E, Abd El-Aty A, Proestos C, Brennan C, Zeng M . Exploring the Potential Medicinal Benefits of : From Metabolic Disorders to Coronavirus Infections. Foods. 2023; 12(7). PMC: 10094145. DOI: 10.3390/foods12071512. View

5.
Liu Y, Shi Y, Zou J, Zhang X, Zhai B, Guo D . Extraction, purification, structural features, biological activities, modifications, and applications from Taraxacum mongolicum polysaccharides: A review. Int J Biol Macromol. 2024; 259(Pt 2):129193. DOI: 10.1016/j.ijbiomac.2023.129193. View